Skip to content
Riskpilot
← Back to search
Sign in
Get full access
MoxieLab ApS
APS
Active
Advertising protection
CVR 42403938
Guldgravervej 3, 3000
Helsingør
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2021 · 5 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
MoxieLab ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-14
-19
-12
-15
-20
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-14
-19
-12
-15
-20
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-14
-19
-12
-15
-20
Net financials
-0
-0
0
-0
0
Profit before tax
-14
-19
-12
-15
-20
Tax
-0
-0
-0
-0
-0
Net profit
-14
-19
-12
-15
-20
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
32
14
2
34
14
Equity
26
8
-4
1
-19
Long-term debt
0
0
0
0
0
Short-term debt
6
6
6
33
33
Total debt
6
6
6
33
33
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1981400.0%
This company
2021
2025
Equity ratio
-134.5%
This company
38.2%
Market median
-452% vs market
2021
2025
Return on equity
-1979000.0%
This company
18.4%
Market median
-10755535% vs market
2021
2025
Net profit margin (of gross profit)
-1979000.0%
This company
2021
2025
Asset turnover (of gross profit)
-1.42×
This company
2021
2025
Debt / equity
1.74×
This company
0.62×
Market median
-181% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-05-20 – 2021-12-31
View
PDF
More on MoxieLab ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
